MARKET

ADVM

ADVM

Adverum
NASDAQ

Real-time Quotes | Nasdaq Last Sale

8.95
+0.42
+4.92%
After Hours: 8.95 0 0.00% 17:01 04/03 EDT
OPEN
8.41
PREV CLOSE
8.53
HIGH
9.06
LOW
8.31
VOLUME
1.07M
TURNOVER
--
52 WEEK HIGH
16.81
52 WEEK LOW
4.200
MARKET CAP
713.15M
P/E (TTM)
-8.9081
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 8 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average ADVM stock price target is 17.17 with a high estimate of 21.00 and a low estimate of 12.00.

EPS

ADVM News

More
  • Edited Transcript of ADVM earnings conference call or presentation 12-Mar-20 8:30pm GMT
  • Thomson Reuters StreetEvents · 4d ago
  • Adverum (ADVM): Strong Industry, Solid Earnings Estimate Revisions
  • Zacks · 03/26 13:55
  • What Makes Adverum Biotechnologies (ADVM) a New Buy Stock
  • Zacks · 03/18 16:00
  • Adverum Biotechnologies, Inc. Analysts Are Cutting Their Estimates: Here's What You Need To Know
  • Simply Wall St. · 03/16 11:06

Industry

Biotechnology & Medical Research
-0.50%
Pharmaceuticals & Medical Research
-0.22%

Hot Stocks

Symbol
Price
%Change

About ADVM

Adverum Biotechnologies, Inc. is a clinical-stage gene therapy company targeting unmet medical needs for serious ocular and rare diseases. The Company is evaluating its gene therapy candidate, ADVM-022, as a one-time, intravitreal injection for the treatment of its lead indication, wet age-related macular degeneration. It has collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize gene therapy products (AVA-311) for ophthalmic diseases. The Company develops gene therapy product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its capabilities include clinical development, vector discovery, and in-house manufacturing, specifically in process development, assay development and current Good Manufacturing Practices (cGMP) quality control.
More

Webull offers kinds of Adverum Biotechnologies Inc stock information, including NASDAQ:ADVM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADVM stock news, and many more online research tools to help you make informed decisions.